Harvard Bioscience Announces Second Quarter 2022 Financial
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the...
Source: globenewswire.com
📰 Harvard Bioscience News
Page 10 - Harvard Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Harvard Bioscience. Real-time updates on events, politics, business and more.
Harvard Bioscience: Q2 Earnings Snapshot
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Wednesday reported second-quarter net income of $2.4 million, after reporting a loss in the same period a year earlier. The Holliston, Massachusetts-based company said it had profit of 6 cents per share.
United States Harvard Bioscience Inc Zacks Investment Research Harvard Bioscience Automated Insights Zacks Investment
Source: apnews.com
Biostage Reports Corporate Highlights and Second Quarter Financial Results
/PRNewswire/ --Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in...
David Green Company Paycheck Protection Program Harvard Bioscience Inc Drug Administration Biostage Inc Company Annual Report On Form
Source: prnewswire.com
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET - Press Release
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. HBIO will announce its financial results for second quarter ended June 30
United States Michael Rossi Harvard Bioscience Harvard Bioscience Inc Investor Relations North America
Source: wiredprnews.com
Celebrating 75 Years in Scientific and Medical Equipment Manufacturing
LTE Scientific, one of the UK’s longest established and highly respected scientific and medical equipment manufacturers, is celebrating 75 years of industry service in 2022. Click to read more...
United Kingdom Karl Fisher Harvard Bioscience Laboratory Thermal Equipment Ltd Tatlock Group Bscientific Ltd
Source: labmate-online.com
Blood Pressure Transducers Market Size to Grow by USD 113.67 million, Increasing Incidence of Hypertension Coupled with the Geriatric Population to Drive Growth
/PRNewswire/ -- The blood pressure transducers market will be driven by factors such as the increasing incidence of hypertension coupled with the geriatric...
United States United Kingdom B Braun Melsungen Jesse Maida Harvard Bioscience Inc Utah Medical Products Inc
Source: prnewswire.com
Insights on the Perfusion System Global Market to 2027 -
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global Perfusion System Market (2022-2027) by Component, Type, Technique, Geography, Competitive Analysis,...
Source: globenewswire.com
Outlook on the Electrophoresis Global Market to 2028 - by Product, Application, End-use and Region By Emergen Research
Market Size – USD 2.66 Billion in 2020, Market Growth – at a CAGR of 5.8%, Market Trend –Rising focus on drug design

United Kingdom British Columbia Harvard Bioscience Biotechnology Companies Electrophoresis Software Academic Research Institutes
Source: einnews.com
TheStreet Downgrades Harvard Bioscience (NASDAQ:HBIO) to D+
Harvard Bioscience (NASDAQ:HBIO – Get Rating) was downgraded by equities research analysts at TheStreet from a “c” rating to a “d+” rating in a research note issued to investors on Monday, TheStreetRatingsTable reports. Several other equities research analysts also recently issued reports on the stock. StockNews.com started coverage on shares of Harvard Bioscience in a […]
United States Harvard Bioscience Harvard Bioscience Inc Securities Exchange Commission Zacks Investment Research B Riley Asset Management
Source: etfdailynews.com
$0.03 EPS Expected for Harvard Bioscience, Inc. (NASDAQ:HBIO) This Quarter
Wall Street brokerages forecast that Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) will post $0.03 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Harvard Bioscience’s earnings. Harvard Bioscience reported earnings per share of $0.06 in the same quarter last year, which indicates a negative […]
United States Harvard Bioscience Harvard Bioscience Inc Securities Exchange Commission Harvard Bioscience Company Profile Get Rating Zacks Investment Research
Source: etfdailynews.com